Universe Pharmaceuticals INC Announces Inclusion of Six Products into the First Edition of Catalogue of Medicine for Patients Infected with COVID-19 - GlobeNewswire

1 year ago 52

Ji’an, Jiangxi, China, Dec. 21, 2022 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical shaper and distributor successful China, contiguous announced that six varieties of the Company’s products were included successful the First Edition of Catalogue of Medicine for Patients Infected with COVID-19 (the “Catalogue”), which was published by Beijing Health Commission connected December 12, 2022. The included products are Banlangen Granules, Strong Loquat Extract, Pediatric Paracetamol, Vitamin C Yinqiao Tablets, Acetaminophen Tablets and Metamizole Sodium Tablets.

The Catalogue supplements the database of recommended medicine successful the Ninth Edition of the National Diagnosis and Treatment Plan. The Catalogue recommends 67 types of accepted Chinese medicine products for six antithetic types of aesculapian symptoms, specified arsenic fever and sore throat, and recommends 41 varieties of occidental medicine products for 4 types of objective symptoms, specified arsenic cough and expectoration. In summation to hospitals, patients tin besides acquisition medicines included successful the Catalogue from channels specified arsenic retail pharmacies and e-commerce platforms according to their ain needs.

Mr. Gang Lai, Chairman and CEO of Universe Pharmaceuticals INC, commented, “We are pleased to person our products included successful the Catalogue. Currently, the bid measurement of our 3 products, Banlangen Granules, Strong Loquat Extract and Pediatric Paracetamol, continues to increase. We volition optimize the proviso concatenation strategy to conscionable the expanding request and strive to guarantee capable proviso of these 3 products for radical to combat against COVID-19 symptoms.”

About Universe Pharmaceuticals INC

Universe Pharmaceuticals INC, headquartered successful Ji’an, Jiangxi, China, is simply a pharmaceutical shaper and distributor successful China. The Company specializes successful the manufacturing, marketing, income and organisation of accepted Chinese medicine derivatives products targeting the aged with the extremity of addressing their carnal conditions successful the aging process and to beforehand their wide well-being. The Company besides distributes and sells biomedical drugs, aesculapian instruments, Traditional Chinese Medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. Currently, the Company’s products are sold successful 30 provinces of China. For much information, sojourn the company’s website at http://www.universe-pharmacy.com/.

Forward-Looking Statements

All statements different than statements of humanities information successful this announcement are forward-looking statements. These forward-looking statements impact known and chartless risks and uncertainties and are based connected existent expectations and projections astir aboriginal events and fiscal trends that the Company believes whitethorn impact its fiscal condition, results of operations, concern strategy and fiscal needs. Investors tin place these forward-looking statements by words oregon phrases specified arsenic may, will, expect, anticipate, aim, estimate, intend, plan, believe, potential, continue, is/are apt to oregon different akin expressions. The Company undertakes nary work to update forward-looking statements to bespeak consequent occurring events oregon circumstances, oregon changes successful its expectations, but arsenic whitethorn beryllium required by law. Although the Company believes that the expectations expressed successful these forward-looking statements are reasonable, it cannot guarantee you that specified expectations volition crook retired to beryllium correct, and the Company cautions investors that existent results whitethorn disagree materially from the anticipated results and encourages investors to reappraisal different factors that whitethorn impact its aboriginal results successful the Company’s registration connection and successful its different filings with the U.S. Securities and Exchange Commission.

For much information, delight contact:

Ascent Investors Relations LLC
Tina Xiao
President
Phone: 917-609-0333
Email: tina.xiao@ascent-ir.com

Read Entire Article